References

  1. Schlipköter U and F A. Communicable diseases: achievements and challenges for public health. Public Health Reviews. 2010; 32(1): p 90-119. Google Scholar

  2. Aljarbou AN. The Emergent Concern of Hepatitis B globally with special attention to Kingdom of Saudi Arabia. Int J Health Sci (Qassim). 2013; 7(3): p 333-40. PubMed | Google Scholar

  3. Lozano R et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): p 2095-128. Google Scholar

  4. Global Burden of Disease Cancer Cet al. The Global Burden of Cancer 2013. JAMA Oncol. 2015; 1(4): p 505-27. Google Scholar

  5. Hsu YC, Wu CY, Lin JT. Hepatitis C virus infection, antiviral therapy, and risk of hepatocellular carcinoma. Semin Oncol. 2015; 42(2): p 329-38. PubMed | Google Scholar

  6. Makara M B. Hunyady, Financial burden of hepatitis C infection and its treatment. Orv Hetil. 2015; 156(21): p 862-8. Google Scholar

  7. Laperche S et al. Blood transfusion: control of infectious risks. Presse Med. 2015; 44(2): p 189-99. Google Scholar

  8. Ott JJ et al. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012; 30(12): p 2212-9. Google Scholar

  9. Karuru JW et al. Prevalence of HCV and HIV/HCV co-infection among volunteer blood donors and VCT clients. East Afr Med J. 2005; 82(4): p 166-9. Google Scholar

  10. Kupek E and Petry A. Changes in the prevalence, incidence and residual risk for HIV and hepatitis C virus in Southern Brazilian blood donors since the implementation of NAT screening. Rev Soc Bras Med Trop. 2014; 47(4): p 418-25. Google Scholar

  11. Namululi BA, Guerrieri C and Dramaix MW. Prevalence and incidence of HIV and hepatitis B among blood donors and estimated residual risk of transmission of HIV and HBV virus by blood transfusion: a study at the Provincial General Referee Hospital Bukavu, Democratic Republic of the Congo. Rev Epidemiol Sante Publique. 2013; 61(2): p 139-44. PubMed | Google Scholar

  12. Willand L et al. HIV, HCV, HBV and syphilis infections among blood donors in Germany 2006: Report from the Robert Koch Institute in accordance with Article 22 of the Transfusion Act. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008; 51(8): p 902-14. Google Scholar

  13. Mohammadali F and Pourfathollah AA. Changes in frequency of HBV, HCV, HIV and syphilis infections among blood donors in Tehran province 2005 - 2011. Arch Iran Med. 2014; 17(9): p 613-20. Google Scholar

  14. Marwaha N and Sachdev S. Current testing strategies for hepatitis C virus infection in blood donors and the way forward. World J Gastroenterol. 2014; 20(11): p 2948-54. Google Scholar

  15. Kafi-abad SA, Rezvan H, Abolghasemi H. Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-200. Transfus Med. 2009; 19(4): p 189-94. PubMed | Google Scholar

  16. Merat S et al. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis. 2010; 14 Suppl 3: p e113-6. Google Scholar

  17. Abdolahi N et al. HBV Seroprevalence among Golestan Adults. Iranian Journal of Epidemiology. 2006; 2(3): p 35-40. Google Scholar

  18. Zali MR et al. Epidemiology of hepatitis B in the Islamic Republic of Iran. 1996;2(2):1996. Google Scholar

  19. Apata IW et al. Progress toward prevention of transfusion-transmitted hepatitis B and hepatitis C infection-sub-Saharan Africa, 2000-2011. MMWR Morb Mortal Wkly Rep. 2014; 63(29): p 613-9. Google Scholar

  20. Malekzadeh R, Khatibian M, Rezvan H. Viral hepatitis in the world and Iran. J Iran Med Council. 2012 May; 14(5): 283-288. Google Scholar

  21. Salehi M et al. Seroepidemiology of HBV infection in South-East of iran; a population based study. Iran Red Crescent Med J. 2012; 14(5): p 283-8. Google Scholar

  22. Alavian SM et al. Seroprevalence of Hepatitis B Virus Infection and Its Risk Factors in the West of Iran: a population-based Study. Int J Prev Med. 2012; 3(11): p 770-5. Google Scholar

  23. Zamani F et al. Prevalence and Risk Factors of Hepatitis C Virus Infection in Amol City, North of Iran: a population-Based Study (2008-2011). Hepat Mon. 2013; 13(12): p e13313. Google Scholar

  24. nokhodiyan Zet al. Hepatitis B Markers in Isfahan, Central Iran: a population-Based Study. Hepat Mon. 2009; 9(1): p 12-16. Google Scholar

  25. Kafi-abad SA et al. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion. 2009; 49(10): p 2214-20. Google Scholar

  26. Kasraian L and Torab Jahromi SA. Prevalence of major transfusion transmitted viral infections (HCV, HBV, HIV) in Shiraz blood donors from 2000 to 2005. The Scientific Journal of Iranian Blood Transfusion Organization. 2007; 3(5): p 373-378. Google Scholar

  27. Mohammadi Z et al. Epidemiological Profile of Hepatitis B Virus Infection in Iran in the Past 25 years; a systematic review and meta-analysis of general population studies. Middle East Journal of Digestive Diseases. 2016; 8(1): p 5-18. Google Scholar

  28. Alavian SM, Fallahian F and Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007; 16(4): p 403-6. PubMed | Google Scholar

  29. Ghadir M et al. Hepatitis C in Golestan Province-Iran. Govaresh. 2006; 11(3): p 158-162. Google Scholar

  30. Namululi BA, Guerrieri C and Dramaix M. Impact of method of recruitment of blood donors on the prevalence of HIV and HBV in Bukavu, DR Congo. Med Sante Trop.2012; 22(1): p 69-74. PubMed | Google Scholar

  31. Schillie S et al. Outcomes of infants born to women infected with hepatitis B. Pediatrics. 2015; 135(5): p e1141-7. Google Scholar

  32. Rezaee R et al. Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): a systematic review and meta-analysis study. Hepat Mon. 2015; 15(5): p e23618. Google Scholar

  33. Dahl TFet al. Health literacy in patients with chronic hepatitis B attending a tertiary hospital in Melbourne: a questionnaire based survey. BMC Infect Dis. 2014; 14: p 537. Google Scholar